BioMarin Pharmaceutical - 25 Year Stock Price History | BMRN

Historical daily share price chart and data for BioMarin Pharmaceutical since 1999 adjusted for splits and dividends. The latest closing stock price for BioMarin Pharmaceutical as of December 05, 2024 is 66.16.
  • The all-time high BioMarin Pharmaceutical stock closing price was 149.13 on July 20, 2015.
  • The BioMarin Pharmaceutical 52-week high stock price is 99.56, which is 50.5% above the current share price.
  • The BioMarin Pharmaceutical 52-week low stock price is 61.15, which is 7.6% below the current share price.
  • The average BioMarin Pharmaceutical stock price for the last 52 weeks is 82.59.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
BioMarin Pharmaceutical Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 81.7785 98.0500 99.0000 61.9300 66.1600 -31.38%
2023 93.7643 100.6100 117.2700 76.2200 96.4200 -6.83%
2022 86.6013 89.3600 108.6300 71.4800 103.4900 17.14%
2021 80.5858 86.3000 91.4700 71.7200 88.3500 0.75%
2020 91.5134 84.0400 131.0300 71.3700 87.6900 3.71%
2019 82.5653 84.9600 98.6200 64.2700 84.5500 -0.70%
2018 92.1163 91.0300 106.0700 76.0100 85.1500 -4.51%
2017 88.8143 85.8400 98.8200 80.6000 89.1700 7.64%
2016 86.6998 104.9200 104.9200 64.7400 82.8400 -20.92%
2015 117.0456 92.1700 149.1300 90.2800 104.7600 15.88%
2014 70.7528 69.2700 94.1900 55.7800 90.4000 28.50%
2013 63.4324 51.9200 78.3880 51.5600 70.3500 42.99%
2012 39.1417 34.9300 50.1700 32.1300 49.2000 43.11%
2011 28.4184 26.6100 35.3800 23.4600 34.3800 27.66%
2010 22.1536 18.9500 28.2500 18.2400 26.9300 43.17%
2009 15.6685 17.6500 20.8300 10.1400 18.8100 5.67%
2008 29.7800 36.6400 40.3900 13.5900 17.8000 -49.72%
2007 21.0564 16.1000 36.5800 15.7100 35.4000 115.99%
2006 14.3090 10.9900 18.0400 10.9600 16.3900 52.04%
2005 7.3643 6.2600 11.4100 4.4300 10.7800 68.70%
2004 6.2104 7.9100 8.7900 3.8700 6.3900 -17.65%
2003 9.4406 7.0300 13.3200 6.4100 7.7600 10.07%
2002 7.2827 13.2400 13.9500 3.6500 7.0500 -47.54%
2001 11.0435 9.5000 14.1600 7.3130 13.4400 38.73%
2000 18.0555 12.7500 38.7500 7.1560 9.6880 -17.55%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $12.676B $2.419B
BioMarin Pharmaceutical Inc. focuses on the development and commercialization of treatments for serious life-threatening medical conditions, mostly for children. The company's portfolio comprises seven marketed products namely, Aldurazyme, Naglazyme, Kuvan a rare genetic enzyme deficiency disorder), Vimizim , Brineura, Palynziq and Voxzogo. BioMarin has a collaboration agreement with Sanofi's subsidiary Genzyme for Aldurazyme. Genzyme is BioMarin's sole customer for Aldurazyme and is responsible for marketing and selling Aldurazyme to third parties.?The newest drug in BioMarin's portfolio, Voxzogo for treating achondroplasia, the most common form of dwarfism. BioMarin's biologics license application (BLA) for Roctavian/valoctocogene roxaparvovec (valrox), a gene therapy for severe hemophilia A, was given a complete response letter (CRL) by the FDA.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $149.574B 14.48
Vertex Pharmaceuticals (VRTX) United States $119.488B 0.00
Bristol Myers Squibb (BMY) United States $118.385B 49.89
Gilead Sciences (GILD) United States $114.145B 20.67
CSL (CSLLY) Australia $88.116B 0.00
Regeneron Pharmaceuticals (REGN) United States $82.885B 18.87
GSK (GSK) United Kingdom $71.296B 8.25
Argenex SE (ARGX) Netherlands $37.727B 0.00
Alnylam Pharmaceuticals (ALNY) United States $32.854B 0.00
BioNTech SE (BNTX) Germany $27.498B 0.00
Biogen (BIIB) United States $23.449B 10.07
Illumina (ILMN) United States $22.601B 82.37
BeiGene (BGNE) Cayman Islands $19.391B 0.00
Moderna (MRNA) United States $16.020B 0.00
Incyte (INCY) United States $14.376B 0.00
Genmab (GMAB) Denmark $14.327B 21.02
Insmed (INSM) United States $13.482B 0.00
Sarepta Therapeutics (SRPT) United States $12.086B 109.08
Bio-Techne Corp (TECH) United States $12.058B 46.56
Exact Sciences (EXAS) United States $11.871B 0.00
Vaxcyte (PCVX) United States $11.596B 0.00
Exelixis (EXEL) United States $10.215B 23.23
QIAGEN (QGEN) Netherlands $9.988B 20.55
Bio-Rad Laboratories (BIO.B) United States $9.437B 32.07
Intra-Cellular Therapies (ITCI) United States $9.112B 0.00
Roivant Sciences (ROIV) United Kingdom $8.815B 0.00
Repligen (RGEN) United States $8.353B 108.82
Revolution Medicines (RVMD) United States $8.117B 0.00
Ascendis Pharma (ASND) Denmark $7.945B 0.00
Legend Biotech (LEGN) United States $7.787B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.463B 7.30
Nuvalent (NUVL) United States $6.695B 0.00
Halozyme Therapeutics (HALO) United States $6.185B 13.97
Blueprint Medicines (BPMC) United States $6.132B 0.00
Cytokinetics (CYTK) United States $5.953B 0.00
Viking Therapeutics (VKTX) United States $5.710B 0.00
Telix Pharmaceuticals (TLX) Australia $5.472B 0.00
Krystal Biotech (KRYS) United States $5.396B 89.34
TG Therapeutics (TGTX) United States $5.274B 0.00
Alkermes (ALKS) Ireland $5.026B 16.88
Axsome Therapeutics (AXSM) United States $4.824B 0.00
ADMA Biologics Inc (ADMA) United States $4.716B 49.88
Guardant Health (GH) United States $4.709B 0.00
Biohaven (BHVN) United States $4.658B 0.00
Arcellx (ACLX) United States $4.642B 0.00
Avidity Biosciences (RNA) United States $4.525B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.365B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.350B 0.00
Apellis Pharmaceuticals (APLS) United States $4.246B 0.00
Immunovant (IMVT) United States $4.186B 0.00
Scholar Rock Holding (SRRK) United States $3.723B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.710B 0.00
Janux Therapeutics (JANX) United States $3.508B 0.00
Denali Therapeutics (DNLI) United States $3.411B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.391B 0.00
ImmunityBio (IBRX) United States $3.303B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $3.261B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.228B 0.00
NovoCure (NVCR) Jersey $3.163B 0.00
SpringWorks Therapeutics (SWTX) United States $3.147B 0.00
Vera Therapeutics (VERA) United States $3.132B 0.00
Merus (MRUS) Netherlands $3.114B 0.00
Twist Bioscience (TWST) United States $3.112B 0.00
Zai Lab (ZLAB) China $3.075B 0.00
Edgewise Therapeutics (EWTX) United States $3.036B 0.00
Kymera Therapeutics (KYMR) United States $2.981B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.956B 0.00
Amicus Therapeutics (FOLD) United States $2.946B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.876B 0.00
Vericel (VCEL) United States $2.870B 969.17
ACADIA Pharmaceuticals (ACAD) United States $2.857B 22.01
Keros Therapeutics (KROS) United States $2.746B 0.00
Iovance Biotherapeutics (IOVA) United States $2.661B 0.00
IDEAYA Biosciences (IDYA) United States $2.450B 0.00
CG Oncology (CGON) United States $2.429B 0.00
Protagonist Therapeutics (PTGX) United States $2.418B 15.26
Geron (GERN) United States $2.418B 0.00
Apogee Therapeutics (APGE) United States $2.342B 0.00
NeoGenomics (NEO) United States $2.312B 0.00
Ligand Pharmaceuticals (LGND) United States $2.286B 57.07
WAVE Life Sciences (WVE) Singapore $2.212B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.183B 0.00
Akero Therapeutics (AKRO) United States $2.158B 0.00
Beam Therapeutics (BEAM) United States $2.155B 0.00
Fortrea Holdings (FTRE) United States $2.129B 67.80
Bavarian Nordic (BVNRY) Denmark $2.117B 12.97
Belite Bio (BLTE) United States $2.051B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.992B 16.55
Tarsus Pharmaceuticals (TARS) United States $1.974B 0.00
Structure Therapeutics (GPCR) United States $1.921B 0.00
Disc Medicine (IRON) United States $1.918B 0.00
MannKind (MNKD) United States $1.875B 48.57
Galapagos (GLPG) Belgium $1.784B 0.00
Celldex Therapeutics (CLDX) United States $1.763B 0.00
Certara (CERT) United States $1.751B 49.46
Arvinas (ARVN) United States $1.745B 0.00
Dynavax Technologies (DVAX) United States $1.694B 99.15
Immunocore Holdings (IMCR) United Kingdom $1.589B 0.00
Viridian Therapeutics (VRDN) United States $1.581B 0.00
Neumora Therapeutics (NMRA) United States $1.578B 0.00
Arcus Biosciences (RCUS) United States $1.565B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.526B 0.00
Travere Therapeutics (TVTX) United States $1.512B 0.00
Myriad Genetics (MYGN) United States $1.511B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.476B 0.00
Intellia Therapeutics (NTLA) United States $1.476B 0.00
Nurix Therapeutics (NRIX) United States $1.475B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.444B 0.00
Spyre Therapeutics (SYRE) United States $1.440B 0.00
MiMedx (MDXG) United States $1.409B 36.88
Day One Biopharmaceuticals (DAWN) United States $1.392B 0.00
Praxis Precision Medicines (PRAX) United States $1.383B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.359B 0.00
Novavax (NVAX) United States $1.330B 0.00
Mesoblast (MESO) Australia $1.307B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.238B 0.00
Upstream Bio (UPB) United States $1.223B 0.00
ANI Pharmaceuticals (ANIP) United States $1.196B 16.29
Septerna (SEPN) United States $1.157B 0.00
Vir Biotechnology (VIR) United States $1.153B 0.00
Bicara Therapeutics (BCAX) United States $1.086B 0.00
Cogent Biosciences (COGT) United States $1.017B 0.00
ArriVent BioPharma (AVBP) United States $0.986B 0.00
LENZ Therapeutics (LENZ) United States $0.985B 0.00
Zymeworks (ZYME) United States $0.972B 0.00
Immatics (IMTX) Germany $0.951B 0.00
Liquidia Technologies (LQDA) United States $0.939B 0.00
Gyre Therapeutics (GYRE) United States $0.928B 0.00
Nuvation Bio (NUVB) United States $0.926B 0.00
Poseida Therapeutics (PSTX) United States $0.917B 0.00
Adaptive Biotechnologies (ADPT) United States $0.906B 0.00
Replimune (REPL) United States $0.901B 0.00
Pliant Therapeutics (PLRX) United States $0.895B 0.00
Castle Biosciences (CSTL) United States $0.893B 159.40
Erasca (ERAS) United States $0.885B 0.00
Pacira BioSciences (PCRX) United States $0.881B 8.30
89BIO (ETNB) United States $0.881B 0.00
Cytek Biosciences (CTKB) United States $0.862B 0.00
AbCellera Biologics (ABCL) Canada $0.857B 0.00
Kura Oncology (KURA) United States $0.851B 0.00
Immunome (IMNM) United States $0.845B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.812B 0.00
CARGO Therapeutics (CRGX) United States $0.802B 0.00
Rapport Therapeutics (RAPP) United States $0.789B 0.00
Avid Bioservices (CDMO) United States $0.785B 0.00
Prothena (PRTA) Ireland $0.782B 0.00
Tyra Biosciences (TYRA) United States $0.778B 0.00
Anavex Life Sciences (AVXL) United States $0.768B 0.00
Tectonic Therapeutic (TECX) United States $0.757B 0.00
Cullinan Therapeutics (CGEM) United States $0.755B 0.00
Entrada Therapeutics (TRDA) United States $0.747B 12.55
AnaptysBio (ANAB) United States $0.733B 0.00
Dianthus Therapeutics (DNTH) United States $0.730B 0.00
Arbutus Biopharma (ABUS) United States $0.709B 0.00
Oric Pharmaceuticals (ORIC) United States $0.692B 0.00
GRAIL (GRAL) United States $0.680B 0.00
Stoke Therapeutics (STOK) United States $0.679B 0.00
BioAge Labs (BIOA) United States $0.649B 0.00
CureVac (CVAC) Germany $0.647B 5.25
Sinovac Biotech (SVA) China $0.645B 0.00
MBX Biosciences (MBX) United States $0.643B 0.00
Oculis Holding AG (OCS) Switzerland $0.629B 0.00
Mineralys Therapeutics (MLYS) United States $0.625B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.612B 0.00
Terns Pharmaceuticals (TERN) United States $0.601B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.598B 0.00
IGM Biosciences (IGMS) United States $0.589B 0.00
CorMedix Inc (CRMD) United States $0.587B 0.00
Sana Biotechnology (SANA) United States $0.583B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.579B 0.00
Olema Pharmaceuticals (OLMA) United States $0.578B 0.00
ChromaDex (CDXC) United States $0.575B 753.00
Astria Therapeutics (ATXS) United States $0.572B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.568B 0.00
Abivax SA (ABVX) France $0.563B 0.00
Cartesian Therapeutics (RNAC) United States $0.559B 0.00
Humacyte (HUMA) United States $0.558B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.552B 0.00
Annexon (ANNX) United States $0.550B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.549B 0.00
Pharming Group (PHAR) Netherlands $0.525B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.516B 0.00
Third Harmonic Bio (THRD) United States $0.516B 0.00
Emergent Biosolutions (EBS) United States $0.511B 0.00
PureTech Health (PRTC) United States $0.492B 0.00
MeiraGTx Holdings (MGTX) United States $0.491B 0.00
Allogene Therapeutics (ALLO) United States $0.473B 0.00
Celcuity (CELC) United States $0.472B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.466B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.465B 0.00
REGENXBIO (RGNX) United States $0.454B 0.00
Revance Therapeutics (RVNC) United States $0.437B 0.00
ACELYRIN, INC (SLRN) United States $0.425B 0.00
Alpha Teknova (TKNO) United States $0.425B 0.00
Aura Biosciences (AURA) United States $0.424B 0.00
Prime Medicine (PRME) United States $0.418B 0.00
GH Research (GHRS) Ireland $0.416B 0.00
Zenas BioPharma (ZBIO) United States $0.411B 0.00
Foghorn Therapeutics (FHTX) United States $0.410B 0.00
Sangamo Therapeutics (SGMO) United States $0.405B 0.00
Codexis (CDXS) United States $0.398B 0.00
MaxCyte (MXCT) United States $0.388B 0.00
Kodiak Sciences (KOD) United States $0.384B 0.00
EnGene Holdings (ENGN) Canada $0.379B 0.00
Tango Therapeutics (TNGX) United States $0.378B 0.00
Alumis (ALMS) United States $0.377B 0.00
XOMA Royalty (XOMA) United States $0.374B 0.00
Northwest Biotherapeutics (NWBO) United States $0.367B 0.00
Contineum Therapeutics (CTNM) United States $0.364B 0.00
Design Therapeutics (DSGN) United States $0.362B 0.00
Absci (ABSI) United States $0.355B 0.00
Kamada (KMDA) Israel $0.348B 21.64
Jasper Therapeutics (JSPR) United States $0.346B 0.00
Voyager Therapeutics (VYGR) United States $0.344B 8.86
Neurogene (NGNE) United States $0.327B 0.00
AC Immune (ACIU) Switzerland $0.317B 0.00
Eton Pharmaceuticals (ETON) United States $0.315B 0.00
Artiva Biotherapeutics (ARTV) United States $0.309B 0.00
UniQure (QURE) Netherlands $0.307B 0.00
ITeos Therapeutics (ITOS) United States $0.299B 0.00
Rezolute (RZLT) United States $0.299B 0.00
Q32 Bio (QTTB) United States $0.298B 0.00
Urogen Pharma (URGN) United States $0.292B 0.00
Fate Therapeutics (FATE) United States $0.292B 0.00
Prima BioMed (IMMP) Australia $0.284B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.283B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.282B 0.00
Mersana Therapeutics (MRSN) United States $0.280B 0.00
Lifecore Biomedical (LFCR) United States $0.280B 0.00
ATyr Pharma (ATYR) United States $0.280B 0.00
Nautilus Biotechnology (NAUT) United States $0.279B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.279B 0.00
C4 Therapeutics (CCCC) United States $0.276B 0.00
Tenaya Therapeutics (TNYA) United States $0.271B 0.00
TuHURA Biosciences (HURA) United States $0.266B 0.00
Atea Pharmaceuticals (AVIR) United States $0.263B 0.00
Abeona Therapeutics (ABEO) United States $0.261B 0.00
Ocugen (OCGN) United States $0.257B 0.00
Anika Therapeutics (ANIK) United States $0.257B 0.00
Verastem (VSTM) United States $0.244B 0.00
Biomea Fusion (BMEA) United States $0.243B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.242B 0.00
TScan Therapeutics (TCRX) United States $0.238B 0.00
Precigen (PGEN) United States $0.236B 0.00
Molecular Partners AG (MOLN) Switzerland $0.235B 0.00
Sutro Biopharma (STRO) United States $0.234B 0.00
DiaMedica Therapeutics (DMAC) United States $0.233B 0.00
Benitec Biopharma (BNTC) United States $0.229B 0.00
BioStem Technologies (BSEM) $0.223B 19.72
Inhibrx Biosciences (INBX) United States $0.219B 0.00
Alector (ALEC) United States $0.214B 0.00
Kyverna Therapeutics (KYTX) United States $0.214B 0.00
Opthea (OPT) Australia $0.211B 0.00
Compass Therapeutics (CMPX) United States $0.208B 0.00
Climb Bio (CLYM) United States $0.208B 0.00
Solid Biosciences (SLDB) United States $0.207B 0.00
Amarin (AMRN) Ireland $0.205B 0.00
GENFIT S.A (GNFT) France $0.205B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.200B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.200B 0.00
Trevi Therapeutics (TRVI) United States $0.200B 0.00
Checkpoint Therapeutics (CKPT) United States $0.199B 0.00
Renovaro (RENB) United States $0.198B 0.00
XBiotech (XBIT) United States $0.198B 0.00
Semper Paratus Acquisition (TVGN) United States $0.198B 0.00
Coherus BioSciences (CHRS) United States $0.197B 0.00
PepGen (PEPG) United States $0.196B 0.00
Nkarta (NKTX) United States $0.192B 0.00
Fulcrum Therapeutics (FULC) United States $0.189B 0.00
2seventy Bio (TSVT) United States $0.188B 0.00
Bright Minds Biosciences (DRUG) United States $0.188B 0.00
Instil Bio (TIL) United States $0.185B 0.00
Caribou Biosciences (CRBU) United States $0.184B 0.00
Ventyx Biosciences (VTYX) United States $0.184B 0.00
Greenwich LifeSciences (GLSI) United States $0.182B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.179B 0.00
Zura Bio (ZURA) United States $0.179B 0.00
ScPharmaceuticals (SCPH) United States $0.173B 0.00
Inozyme Pharma (INZY) United States $0.173B 0.00
Cabaletta Bio (CABA) United States $0.172B 0.00
Actuate Therapeutics (ACTU) United States $0.171B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.169B 0.00
Adherex Technologies (FENC) United States $0.167B 0.00
Editas Medicine (EDIT) United States $0.164B 0.00
Elutia (ELUT) United States $0.164B 0.00
Sagimet Biosciences (SGMT) United States $0.161B 0.00
Applied Therapeutics (APLT) United States $0.161B 0.00
Gossamer Bio (GOSS) United States $0.159B 0.00
Puma Biotechnology (PBYI) United States $0.155B 6.58
Seer (SEER) United States $0.146B 0.00
Candel Therapeutics (CADL) United States $0.144B 0.00
Bluebird Bio (BLUE) United States $0.143B 0.00
Compugen (CGEN) Israel $0.142B 79.50
Cidara Therapeutics (CDTX) United States $0.141B 0.00
Seres Therapeutics (MCRB) United States $0.140B 0.00
InflaRx (IFRX) Germany $0.140B 0.00
Black Diamond Therapeutics (BDTX) United States $0.139B 0.00
Inventiva S.A (IVA) France $0.137B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.136B 0.00
Monopar Therapeutics (MNPR) United States $0.130B 0.00
Adverum Biotechnologies (ADVM) United States $0.125B 0.00
Repare Therapeutics (RPTX) Canada $0.123B 0.00
Cardiff Oncology (CRDF) United States $0.123B 0.00
Scilex Holding (SCLX) United States $0.122B 0.00
CAMP4 Therapeutics (CAMP) United States $0.119B 0.00
Leap Therapeutics (LPTX) United States $0.118B 0.00
Innate Pharma S.A (IPHA) France $0.117B 0.00
Skye Bioscience (SKYE) United States $0.117B 0.00
TELA Bio (TELA) United States $0.114B 0.00
Immunic (IMUX) United States $0.113B 0.00
Alto Neuroscience (ANRO) United States $0.112B 0.00
INmune Bio (INMB) United States $0.112B 0.00
MediciNova (MNOV) United States $0.111B 0.00
Rani Therapeutics Holdings (RANI) United States $0.111B 0.00
Abpro Holdings (ABP) United States $0.110B 0.00
Akoya Biosciences (AKYA) United States $0.109B 0.00
Inovio Pharmaceuticals (INO) United States $0.108B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.108B 0.00
Cellectis S.A (CLLS) France $0.105B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.104B 0.00
Coya Therapeutics (COYA) United States $0.102B 0.00
CytomX Therapeutics (CTMX) United States $0.101B 7.59
BioHarvest Sciences (BHST) Canada $0.101B 0.00
Allakos (ALLK) United States $0.100B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.099B 0.00
Genelux (GNLX) United States $0.098B 0.00
Adagene (ADAG) China $0.097B 0.00
Genenta Science S.p.A (GNTA) Italy $0.096B 0.00
HilleVax (HLVX) United States $0.096B 0.00
Nuvectis Pharma (NVCT) United States $0.093B 0.00
Aligos Therapeutics (ALGS) United States $0.093B 0.00
Vigil Neuroscience (VIGL) United States $0.092B 0.00
Generation Bio (GBIO) United States $0.091B 0.00
23andMe Holding (ME) United States $0.089B 0.00
I-Mab (IMAB) China $0.089B 0.00
Quince Therapeutics (QNCX) United States $0.088B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.086B 0.00
FibroBiologics (FBLG) United States $0.085B 0.00
Adlai Nortye (ANL) Cayman Islands $0.084B 0.00
Adicet Bio (ACET) United States $0.084B 0.00
Invizyne Technologies (IZTC) United States $0.083B 0.00
Annovis Bio (ANVS) United States $0.083B 0.00
ALX Oncology Holdings (ALXO) United States $0.082B 0.00
Ikena Oncology (IKNA) United States $0.082B 0.00
Agenus (AGEN) United States $0.080B 0.00
PDS Biotechnology (PDSB) United States $0.080B 0.00
DBV Technologies S.A (DBVT) France $0.079B 0.00
Werewolf Therapeutics (HOWL) United States $0.079B 0.00
Chimerix (CMRX) United States $0.078B 0.00
Galena Biopharma (SLS) United States $0.078B 0.00
BioAtla (BCAB) United States $0.078B 0.00
Clearside Biomedical (CLSD) United States $0.077B 0.00
Invivyd (IVVD) United States $0.076B 0.00
Ovid Therapeutics (OVID) United States $0.075B 0.00
Aerovate Therapeutics (AVTE) United States $0.074B 0.00
VistaGen Therapeutics (VTGN) United States $0.073B 0.00
Atara Biotherapeutics (ATRA) United States $0.071B 0.00
Immuneering (IMRX) United States $0.071B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.071B 0.00
Oncolytics Biotech (ONCY) Canada $0.068B 0.00
ZIVO Bioscience (ZIVO) United States $0.067B 0.00
BeyondSpring (BYSI) United States $0.066B 0.00
Theratechnologies (THTX) Canada $0.065B 0.00
Cue Biopharma (CUE) United States $0.065B 0.00
X4 Pharmaceuticals (XFOR) United States $0.065B 0.00
Spero Therapeutics (SPRO) United States $0.064B 16.86
Immix Biopharma (IMMX) United States $0.064B 0.00
Entera Bio (ENTX) Israel $0.063B 0.00
BGM Group (BGM) China $0.062B 0.00
Connect Biopharma Holdings (CNTB) United States $0.062B 0.00
Vor Biopharma (VOR) $0.061B 0.00
Aadi Bioscience (AADI) United States $0.060B 0.00
Boundless Bio (BOLD) United States $0.060B 0.00
Fortress Biotech (FBIO) United States $0.060B 0.00
CervoMed (CRVO) United States $0.060B 0.00
Shattuck Labs (STTK) United States $0.060B 0.00
Kronos Bio (KRON) United States $0.057B 0.00
Exicure (XCUR) United States $0.056B 0.00
Enzo Biochem (ENZ) United States $0.055B 0.00
IO Biotech (IOBT) Denmark $0.055B 0.00
Elicio Therapeutics (ELTX) United States $0.055B 0.00
VTv Therapeutics (VTVT) United States $0.053B 0.00
Omega Therapeutics (OMGA) United States $0.053B 0.00
Kezar Life Sciences (KZR) United States $0.051B 0.00
Aileron Therapeutics (ALRN) United States $0.051B 0.00
Dyadic (DYAI) United States $0.049B 0.00
Celularity (CELU) United States $0.048B 0.00
Precision BioSciences (DTIL) United States $0.047B 0.00
OnKure Therapeutics (OKUR) United States $0.047B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.046B 0.00
Passage Bio (PASG) United States $0.046B 0.00
Xilio Therapeutics (XLO) United States $0.046B 0.00
Rallybio (RLYB) United States $0.045B 0.00
Lexaria Bioscience (LEXX) Canada $0.045B 0.00
AN2 Therapeutics (ANTX) United States $0.045B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.044B 0.00
Estrella Immunopharma (ESLA) United States $0.043B 0.00
Grace Therapeutics (GRCE) Canada $0.041B 0.00
Lantern Pharma (LTRN) United States $0.041B 0.00
CalciMedica (CALC) United States $0.041B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.040B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.040B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.040B 0.00
Affimed (AFMD) Germany $0.040B 0.00
Oncobiologics (OTLK) United States $0.039B 0.00
Opus Genetics (IRD) United States $0.038B 0.00
BRIACELL THERAP (BCTX) Canada $0.038B 0.00
Lumos Pharma (LUMO) United States $0.037B 0.00
Intensity Therapeutics (INTS) United States $0.037B 0.00
Rapt Therapeutics (RAPT) United States $0.037B 0.00
Beyond Air (XAIR) United States $0.036B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.035B 0.00
Alpha Cognition (ACOG) Canada $0.035B 0.00
Clene (CLNN) United States $0.034B 0.00
OKYO Pharma (OKYO) $0.034B 0.00
Curis (CRIS) United States $0.034B 0.00
Elevation Oncology (ELEV) United States $0.034B 0.00
Forte Biosciences (FBRX) United States $0.033B 0.00
NextCure (NXTC) United States $0.032B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.032B 0.00
Promis Neurosciences (PMN) Canada $0.031B 0.00
KALA BIO (KALA) United States $0.031B 0.00
Medicus Pharma (MDCX) Canada $0.030B 0.00
Senti Biosciences (SNTI) United States $0.030B 0.00
HOOKIPA Pharma (HOOK) United States $0.030B 0.00
Longeveron (LGVN) United States $0.030B 0.00
RenovoRx (RNXT) United States $0.029B 0.00
Dare Bioscience (DARE) United States $0.028B 0.00
MiNK Therapeutics (INKT) United States $0.028B 0.00
Pluri (PLUR) Israel $0.028B 0.00
SAB Biotherapeutics (SABS) United States $0.027B 0.00
LakeShore Biopharma (LSB) China $0.027B 0.00
Equillium (EQ) United States $0.025B 0.00
Femasys (FEMY) United States $0.025B 0.00
Ocean Biomedical (OCEA) United States $0.025B 0.00
Bionano Genomics (BNGO) United States $0.024B 0.00
Athira Pharma (ATHA) United States $0.024B 0.00
Chemomab Therapeutics (CMMB) Israel $0.024B 0.00
Lisata Therapeutics (LSTA) United States $0.023B 0.00
Gelteq (GELS) Australia $0.023B 0.00
Bolt Biotherapeutics (BOLT) United States $0.022B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.022B 0.00
IN8bio (INAB) United States $0.022B 0.00
Pulmatrix (PULM) United States $0.022B 0.00
Cadrenal Therapeutics (CVKD) United States $0.022B 0.00
Spruce Biosciences (SPRB) United States $0.021B 0.00
Tenax Therapeutics (TENX) United States $0.021B 0.00
GeoVax Labs (GOVX) United States $0.021B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.021B 0.00
MetaVia (MTVA) United States $0.021B 0.00
Cocrystal Pharma (COCP) United States $0.020B 0.00
Cyclo Therapeutics (CYTH) United States $0.019B 0.00
UNITY Biotechnology (UBX) United States $0.019B 0.00
NKGen Biotech (NKGN) United States $0.018B 0.00
Cyclerion Therapeutics (CYCN) United States $0.017B 0.00
BioXcel Therapeutics (BTAI) United States $0.017B 0.00
Aprea Therapeutics (APRE) United States $0.017B 0.00
Synlogic (SYBX) United States $0.017B 0.00
BioAffinity Technologies (BIAF) United States $0.016B 0.00
HCW Biologics (HCWB) United States $0.016B 0.00
Cognition Therapeutics (CGTX) United States $0.016B 0.00
Novogen (KZIA) Australia $0.015B 0.00
Cara Therapeutics (CARA) United States $0.015B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.015B 0.00
Prana Biotechnology (ATHE) Australia $0.014B 0.00
Cingulate (CING) United States $0.014B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.013B 0.00
Sensei Biotherapeutics (SNSE) United States $0.013B 0.00
Imunon (IMNN) United States $0.012B 0.00
Turnstone Biologics (TSBX) United States $0.012B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
Apollomics (APLM) United States $0.011B 0.00
Aptose Biosciences (APTO) Canada $0.011B 0.00
Vaccinex (VCNX) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.010B 0.00
Ensysce Biosciences (ENSC) United States $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Aytu BioPharma (AYTU) United States $0.010B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.009B 0.00
Mustang Bio (MBIO) United States $0.009B 0.00
GENPREX (GNPX) United States $0.009B 0.00
Eyenovia (EYEN) United States $0.008B 0.00
Evaxion Biotech (EVAX) Denmark $0.008B 0.00
Quantum Biopharma (QNTM) Canada $0.008B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.008B 0.00
Vincerx Pharma (VINC) United States $0.008B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
Soligenix (SNGX) United States $0.008B 0.00
Edesa Biotech (EDSA) Canada $0.008B 0.00
Evogene (EVGN) Israel $0.008B 0.00
Adial Pharmaceuticals (ADIL) United States $0.008B 0.00
Galecto (GLTO) Denmark $0.008B 0.00
Moleculin Biotech (MBRX) United States $0.008B 0.00
Organovo Holdings (ONVO) United States $0.008B 0.00
Carmell (CTCX) United States $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
Syros Pharmaceuticals (SYRS) United States $0.007B 0.00
Biora Therapeutics (BIOR) United States $0.006B 0.00
Purple Biotech (PPBT) Israel $0.006B 0.00
CNS Pharmaceuticals (CNSP) United States $0.006B 0.00
GT Biopharma (GTBP) United States $0.006B 0.00
GRI Bio (GRI) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.006B 0.00
Elevai Labs (ELAB) United States $0.005B 0.00
Onconetix (ONCO) United States $0.005B 0.00
Aptevo Therapeutics (APVO) United States $0.005B 0.00
Allarity Therapeutics (ALLR) United States $0.005B 0.00
Bionomics (BNOX) Australia $0.005B 0.00
Alzamend Neuro (ALZN) United States $0.005B 0.00
NAYA Biosciences (NAYA) United States $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.005B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.005B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.004B 0.00
Silo Pharma (SILO) United States $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Portage Biotech (PRTG) $0.004B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Windtree Therapeutics (WINT) United States $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Pasithea Therapeutics (KTTA) United States $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Dogwood Therapeutics (DWTX) United States $0.003B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
Citius Oncology (CTOR) United States $0.003B 0.00
NuCana (NCNA) United Kingdom $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Dermata Therapeutics (DRMA) United States $0.003B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Psyence Biomedical (PBM) Canada $0.002B 0.00
Revelation Biosciences (REVB) United States $0.002B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.002B 0.00
Eterna Therapeutics (ERNA) United States $0.002B 0.00
TFF Pharmaceuticals (TFFP) United States $0.001B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) Luxembourg $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
NeuBase Therapeutics (NBSE) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00